亚盛医药-B(06855)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

06855 亚盛医药-B

休市中 12-05 16:09:08

63.550

+2.700

+4.44%

最高65.000	最低61.150	成交量199.14万
今开62.850	昨收60.850	日振幅6.33%
总市值237.04亿	流通市值237.04亿	总股本3.73亿
成交额1.25亿	换手率0.53%	流通股本3.73亿
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

数据加载中...

北京优虎网络科技有限公司

免责声明:香港交易所资讯服务有限公司、其控股公司及／或该等控股公司的任何附属公司均竭力确保所提供信息的准确和可靠度，但不能保证其绝对准确和可靠，且亦不会承担因任何不准确或遗漏而引起的任何损失或损害的责任（不管是否侵权法下的责任或合约责任又或其它责任）

{"stockData":{"symbol":"06855","market":"HK","secType":"STK","nameCN":"亚盛医药-B","latestPrice":63.55,"timestamp":1764922148007,"preClose":60.85,"halted":0,"volume":1991400,"delay":0,"floatShares":373000000,"shares":373000000,"eps":-1.4782746051707625,"marketStatus":"休市中","change":2.7,"latestTime":"12-05 16:09:08","open":62.85,"high":65,"low":61.15,"amount":125166423,"amplitude":0.06327,"askPrice":63.55,"askSize":10200,"bidPrice":63.35,"bidSize":4700,"shortable":3,"etf":0,"ttmEps":-3.904526226043766,"tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1765157400000},"marketStatusCode":7,"adr":0,"listingDate":1572192000000,"exchange":"SEHK","adjPreClose":60.85,"openAndCloseTimeList":[[1764898200000,1764907200000],[1764910800000,1764921600000]],"volumeRatio":1.598558936965497,"lotSize":100,"spreadScale":0,"tradeCurrency":"HKD"},"requestUrl":"/m/hq/s/06855","defaultTab":"news","newsList":[{"id":"2589519008","title":"港股异动 | 亚盛医药-B(06855)涨超6% 耐立克®POLARIS-1研究获美国FDA和欧洲EMA批准","url":"https://stock-news.laohu8.com/highlight/detail?id=2589519008","media":"智通财经","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2589519008?lang=zh_cn&edition=full","pubTime":"2025-12-05 09:33","pubTimestamp":1764898401,"startTime":"0","endTime":"0","summary":"智通财经APP获悉，亚盛医药-B涨超6%，截至发稿，涨5.67%，报64.2港元，成交额1993.31万港元。消息面上，12月5日，亚盛医药-B发布公告，公司原创1类新药奥雷巴替尼联合化疗治疗新诊断费城染色体阳性(Ph+)急性淋巴细胞白血病患者的全球注册III期临床研究获美国食品药品监督管理局和欧洲药品管理局同意开展。作为耐立克在欧美监管机构获批的第二个全球注册III期研究，POLARIS-1研究在多国家多中心同步入组，将加速耐立克全球特别是欧美市场的上市进程。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1377993.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK1574","AAPG","BK1161","EMA","BK4139","06855","BK4081"],"gpt_icon":0},{"id":"2589985521","title":"亚盛医药-B(06855)耐立克®一线治疗Ph+ ALL的全球注册III期临床研究获美国FDA和欧洲EMA批准","url":"https://stock-news.laohu8.com/highlight/detail?id=2589985521","media":"智通财经","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2589985521?lang=zh_cn&edition=full","pubTime":"2025-12-05 08:03","pubTimestamp":1764893004,"startTime":"0","endTime":"0","summary":"智通财经APP讯，亚盛医药-B 发布公告，公司原创1类新药奥雷巴替尼联合化疗治疗新诊断费城染色体阳性(Ph+)急性淋巴细胞白血病患者的全球注册III期临床研究获美国食品药品监督管理局和欧洲药品管理局同意开展。同时，耐立克在Ph+ ALL领域深度布局，针对Ph+ ALL领域的治疗已获《CSCO恶性血液病诊疗指南》连续推荐，并获CDE突破性疗法认定。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1377959.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["EMA","LU0985320562.USD","LU1571399168.USD","AAPG","06855","BK4107","BK4134","BK4585","III","BK4139","LU1699723380.USD","LU2355687059.USD","BK1574","BK1161","ALL","BK4533","BK4081","BK4588"],"gpt_icon":0},{"id":"1111109965","title":"亚盛医药-B - 全球注册性III期研究获FDA和EMA批准","url":"https://stock-news.laohu8.com/highlight/detail?id=1111109965","media":"美股速递","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1111109965?lang=zh_cn&edition=full","pubTime":"2025-12-05 07:59","pubTimestamp":1764892749,"startTime":"0","endTime":"0","summary":"亚盛医药-B - 全球注册性III期研究获FDA和EMA批准","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["06855","BK1161","BK1574"],"gpt_icon":0},{"id":"1140121331","title":"亚盛医药集团（06855）2025年11月股份变动月报，股本维持稳定","url":"https://stock-news.laohu8.com/highlight/detail?id=1140121331","media":"公告速递","labels":["SGX"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1140121331?lang=zh_cn&edition=full","pubTime":"2025-12-04 21:26","pubTimestamp":1764854814,"startTime":"0","endTime":"0","summary":"亚盛医药集团于2025年12月4日披露了截至2025年11月30日的股份变动月报表。公告显示，公司于本报告期内未进行任何股份发行、购回或注销，股本情况整体保持稳定。公司目前的法定注册股本为500,000,000股，面值每股USD 0.0001，总额USD 50,000，报告期内无变动。已发行股份总数与上月一致，维持在373,321,622股，未有库藏股份。与此同时，2022年受限制股份单位计划现有1,655,411股的可发行上限，但本月无实际发股或转让。本次月报由公司秘书陈焯墁签署。","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["06855"],"gpt_icon":0},{"id":"2589346518","title":"每日卖空追踪 | 亚盛医药-B 12月04日卖空量成交3.85万股，卖空比例为3.12%","url":"https://stock-news.laohu8.com/highlight/detail?id=2589346518","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2589346518?lang=zh_cn&edition=full","pubTime":"2025-12-04 16:30","pubTimestamp":1764837037,"startTime":"0","endTime":"0","summary":"亚盛医药-B北京时间12月04日，涨1.59%，卖空量成交3.85万股，较上一交易日减少72.02%更多个股卖空数据请看下面视窗：卖空数据是观测市场多空博弈的关键指标：短期可反映市场情绪，高卖空比例预示看空预期，但极端值可能触发轧空反弹；长期结合基本面恶化则预警下行风险。需注意其局限性：卖空行为包含对冲需求，未必单纯看空；机构可能通过衍生品做空未体现在数据中，且散户跟风易扭曲信号。股市有风险，请谨慎决策。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251204163630978f88f2&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251204163630978f88f2&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1574","06855","BK1161"],"gpt_icon":0},{"id":"2589664834","title":"亚盛医药-B12月04日主力净流入878.2万元 散户资金抛售","url":"https://stock-news.laohu8.com/highlight/detail?id=2589664834","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2589664834?lang=zh_cn&edition=full","pubTime":"2025-12-04 16:15","pubTimestamp":1764836140,"startTime":"0","endTime":"0","summary":"12月04日, 亚盛医药-B股价涨1.59%，报收60.85元，成交金额7500.8万元，换手率0.33%，振幅3.09%，量比0.95。亚盛医药-B今日主力资金净流入878.2万元，上一交易日主力净流出342.6万元。该股近5个交易日下跌5.87%，主力资金累计净流入20.1万元，其中1个交易日为股价上涨时净流出；近20日主力资金累计净流出1435.2万元，其中净流出天数为11日。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251204161833a4cc2e00&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251204161833a4cc2e00&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["06855","BK1161","BK1574"],"gpt_icon":0},{"id":"1114028107","title":"港股生物医药股午后跌幅持续扩大，歌礼制药-B跌超11%","url":"https://stock-news.laohu8.com/highlight/detail?id=1114028107","media":"老虎资讯综合","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1114028107?lang=zh_cn&edition=full","pubTime":"2025-12-03 13:12","pubTimestamp":1764738746,"startTime":"0","endTime":"0","summary":"12月3日，港股生物医药股午后跌幅持续扩大，$歌礼制药-B(01672)$跌超11%，$华领医药-B(02552)$跌近8%，$迈博药业-B(02181)$跌近7%，$德琪医药-B(06996)$跌超5%，$亚盛医药-B(06855)$跌超4%。","market":"hk","thumbnail":"https://static.tigerbbs.com/85675909dc6c67ee0181339c18bcfdff","type":0,"news_type":0,"thumbnails":["https://static.tigerbbs.com/85675909dc6c67ee0181339c18bcfdff"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"c54c8d8de852bbfb4567c558a904e399","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":true,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["01672","BK1161","02552","01477","BK1515","BK1191","06855","06996","BK1574","BK1583","02181"],"gpt_icon":0},{"id":"2588157774","title":"每日卖空追踪 | 亚盛医药-B 12月01日卖空量成交2.56万股，卖空比例为2.01%","url":"https://stock-news.laohu8.com/highlight/detail?id=2588157774","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2588157774?lang=zh_cn&edition=full","pubTime":"2025-12-01 16:30","pubTimestamp":1764577836,"startTime":"0","endTime":"0","summary":"亚盛医药-B北京时间12月01日，跌0.7%，卖空量成交2.56万股，较上一交易日减少70.94%更多个股卖空数据请看下面视窗：卖空数据是观测市场多空博弈的关键指标：短期可反映市场情绪，高卖空比例预示看空预期，但极端值可能触发轧空反弹；长期结合基本面恶化则预警下行风险。需注意其局限性：卖空行为包含对冲需求，未必单纯看空；机构可能通过衍生品做空未体现在数据中，且散户跟风易扭曲信号。股市有风险，请谨慎决策。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251201163549a71c72b2&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251201163549a71c72b2&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["06855","BK1574","BK1161"],"gpt_icon":0},{"id":"2588774184","title":"亚盛医药-B12月01日遭主力抛售387.5万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2588774184","media":"市场透视","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2588774184?lang=zh_cn&edition=full","pubTime":"2025-12-01 16:15","pubTimestamp":1764576908,"startTime":"0","endTime":"0","summary":"12月01日, 亚盛医药-B股价跌0.70%，报收63.70元，成交金额8087.6万元，换手率0.34%，振幅2.57%，量比0.97。亚盛医药-B今日主力资金净流出387.5万元，上一交易日主力净流出16.4万元。该股近5个交易日上涨3.15%，主力资金累计净流入180.0万元；近20日主力资金累计净流出2611.2万元，其中净流出天数为12日。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251201161522978949f8&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251201161522978949f8&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["06855","BK1161","BK1574"],"gpt_icon":0},{"id":"2586467228","title":"亚盛医药-B(06855)授出130.45万份受限制股份单位及73.66万份购股权","url":"https://stock-news.laohu8.com/highlight/detail?id=2586467228","media":"智通财经","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2586467228?lang=zh_cn&edition=full","pubTime":"2025-11-27 21:18","pubTimestamp":1764249535,"startTime":"0","endTime":"0","summary":"智通财经APP讯，亚盛医药-B(06855)发布公告，截至本公告日期，已根据2022年受限制股份单位计划向2022年受限制股份单位计划的146名获选人士授出130.45万份受限制股份单位，相当于130.45万股股份(2022年进一步授出)。截至本公告日期，公司根据首次公开发售后购股权计划条款向34名获授人授出合共73.66万份购股权，可于行使有关购股权时认购合共73.66万股公司普通股，惟须待购股权获授人接纳后方可作实。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1374751.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["06855","AAPG","BK1161","BK1574","BK4139"],"gpt_icon":0},{"id":"2586325574","title":"每日卖空追踪 | 亚盛医药-B 11月26日卖空量成交8.62万股，卖空比例为6.37%","url":"https://stock-news.laohu8.com/highlight/detail?id=2586325574","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2586325574?lang=zh_cn&edition=full","pubTime":"2025-11-26 16:30","pubTimestamp":1764145833,"startTime":"0","endTime":"0","summary":"亚盛医药-B北京时间11月26日，涨1.44%，卖空量成交8.62万股，较上一交易日减少27.2%更多个股卖空数据请看下面视窗：卖空数据是观测市场多空博弈的关键指标：短期可反映市场情绪，高卖空比例预示看空预期，但极端值可能触发轧空反弹；长期结合基本面恶化则预警下行风险。需注意其局限性：卖空行为包含对冲需求，未必单纯看空；机构可能通过衍生品做空未体现在数据中，且散户跟风易扭曲信号。股市有风险，请谨慎决策。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251126163559a4bb6018&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251126163559a4bb6018&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["06855","BK1574","BK1161"],"gpt_icon":0},{"id":"2586825508","title":"亚盛医药-B11月26日获主力加仓50.7万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2586825508","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2586825508?lang=zh_cn&edition=full","pubTime":"2025-11-26 16:15","pubTimestamp":1764144940,"startTime":"0","endTime":"0","summary":"11月26日, 亚盛医药-B股价涨1.44%，报收63.35元，成交金额8818.6万元，换手率0.37%，振幅3.76%，量比0.94。亚盛医药-B今日主力资金净流入50.7万元，上一交易日主力净流入66.3万元。该股近5个交易日上涨0.24%，主力资金累计净流入211.8万元，其中1个交易日为股价下跌时净流入；近20日主力资金累计净流出1942.2万元，其中净流出天数为10日。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251126161914951b43c4&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251126161914951b43c4&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["06855","BK1161","BK1574"],"gpt_icon":0},{"id":"2586284951","title":"港股亚盛医药-B涨超3%","url":"https://stock-news.laohu8.com/highlight/detail?id=2586284951","media":"每日经济新闻","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2586284951?lang=zh_cn&edition=full","pubTime":"2025-11-26 11:03","pubTimestamp":1764126180,"startTime":"0","endTime":"0","summary":"每经AI快讯，亚盛医药-B(06855.HK)涨超3%，截至发稿，涨3.04%，报64.35港元，成交额4604.84万港元。\n\n\n海量资讯、精准解读，尽在新浪财经APP","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"sina","url":"https://finance.sina.com.cn/roll/2025-11-26/doc-infysxme3338276.shtml","rn_cache_url":null,"customStyle":"body{padding-top:10px;}.art_tit_h1{#titleStyle#}a{#lv2TextColor#}.art_time, .art_cite{#sourceStyle#;} .art_cite{margin-left: 3px;}","selectors":".module-article, article","filters":"header, .voice2, .tags, #norm_qrcode_link_auto, .unfold-box, .action","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/roll/2025-11-26/doc-infysxme3338276.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["BK4139","06855","AAPG","BK1574","BK1161"],"gpt_icon":0},{"id":"2586281468","title":"港股异动 | 亚盛医药-B(06855)涨超3% 首次揭示奥雷巴替尼通过调控脂质代谢发挥抗肿瘤作用全新机制","url":"https://stock-news.laohu8.com/highlight/detail?id=2586281468","media":"智通财经","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2586281468?lang=zh_cn&edition=full","pubTime":"2025-11-26 10:47","pubTimestamp":1764125279,"startTime":"0","endTime":"0","summary":"智通财经APP获悉，亚盛医药-B涨超3%，截至发稿，涨3.04%，报64.35港元，成交额4604.84万港元。研究结果表明奥雷巴替尼在琥珀酸脱氢酶缺陷型GIST中具有良好的疗效与安全性，并首次揭示奥雷巴替尼通过调控脂质代谢发挥抗肿瘤作用的全新机制。据悉，这是迄今为止针对该罕见GIST亚型规模最大的前瞻性临床试验。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1373726.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK1161","AAPG","06855","BK4139","BK1574"],"gpt_icon":0},{"id":"2586419233","title":"每日卖空追踪 | 亚盛医药-B 11月24日卖空量成交2.71万股，卖空比例为2.06%","url":"https://stock-news.laohu8.com/highlight/detail?id=2586419233","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2586419233?lang=zh_cn&edition=full","pubTime":"2025-11-24 16:30","pubTimestamp":1763973035,"startTime":"0","endTime":"0","summary":"亚盛医药-B北京时间11月24日，涨2.31%，卖空量成交2.71万股，较上一交易日减少81.27%更多个股卖空数据请看下面视窗：卖空数据是观测市场多空博弈的关键指标：短期可反映市场情绪，高卖空比例预示看空预期，但极端值可能触发轧空反弹；长期结合基本面恶化则预警下行风险。需注意其局限性：卖空行为包含对冲需求，未必单纯看空；机构可能通过衍生品做空未体现在数据中，且散户跟风易扭曲信号。股市有风险，请谨慎决策。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251124163541a4b6a5dc&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251124163541a4b6a5dc&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1161","BK1574","06855"],"gpt_icon":0},{"id":"2585176074","title":"每日卖空追踪 | 亚盛医药-B 11月21日卖空量成交9.22万股，卖空比例为4.88%","url":"https://stock-news.laohu8.com/highlight/detail?id=2585176074","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2585176074?lang=zh_cn&edition=full","pubTime":"2025-11-21 16:30","pubTimestamp":1763713836,"startTime":"0","endTime":"0","summary":"亚盛医药-B北京时间11月21日，跌5.25%，卖空量成交9.22万股，较上一交易日增加5.86%更多个股卖空数据请看下面视窗：卖空数据是观测市场多空博弈的关键指标：短期可反映市场情绪，高卖空比例预示看空预期，但极端值可能触发轧空反弹；长期结合基本面恶化则预警下行风险。需注意其局限性：卖空行为包含对冲需求，未必单纯看空；机构可能通过衍生品做空未体现在数据中，且散户跟风易扭曲信号。股市有风险，请谨慎决策。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251121163558a70896e6&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251121163558a70896e6&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["06855","BK1161","BK1574"],"gpt_icon":0},{"id":"2584142159","title":"专注细分赛道，这三家药企把“长期主义”进行到底","url":"https://stock-news.laohu8.com/highlight/detail?id=2584142159","media":"制药在线","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2584142159?lang=zh_cn&edition=full","pubTime":"2025-11-19 14:02","pubTimestamp":1763532126,"startTime":"0","endTime":"0","summary":"近日，百利天恒宣布延迟港股全球发售及上市计划，将原定于11月17日在港交所挂牌交易的计划紧急暂停。通过复盘这三家药企的基本盘，不难发现，坚持践行“长期主义”是几家药企保持长青的秘诀。在EGFR野生型非鳞状NSCLC患者中，ORR高达47.4%。目前，GQ1005处于III期临床研究阶段，拟用于治疗HER2+乳腺癌。复宏汉霖在肺癌、乳腺癌两大领域，已构建起覆盖“全程全域全球”的治疗生态。目前，奥雷巴替尼已上市的所有适应症均已纳入国家医保药品目录。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251119140220950dc360&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251119140220950dc360&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["06855","02696","BK1515","BK1161","09939","BK1574"],"gpt_icon":0},{"id":"2584327965","title":"亚盛医药盘中异动 早盘急速下跌7.00%","url":"https://stock-news.laohu8.com/highlight/detail?id=2584327965","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2584327965?lang=zh_cn&edition=full","pubTime":"2025-11-19 00:00","pubTimestamp":1763481637,"startTime":"0","endTime":"0","summary":"北京时间2025年11月19日00时00分，亚盛医药股票出现异动，股价大幅跳水7.00%。截至发稿，该股报30.42美元/股，成交量594股，换手率0.00%，振幅0.52%。机构评级方面，在所有3家参与评级的机构中，100%的券商给予买入建议，无券商给予持有、卖出建议。亚盛医药股票所在的生物技术行业中，整体跌幅为0.33%。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251119000037a70249a5&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251119000037a70249a5&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["06855","BK4139","AAPG"],"gpt_icon":0},{"id":"2584966214","title":"每日卖空追踪 | 亚盛医药-B 11月18日卖空量成交4.53万股，卖空比例为3.26%","url":"https://stock-news.laohu8.com/highlight/detail?id=2584966214","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2584966214?lang=zh_cn&edition=full","pubTime":"2025-11-18 16:30","pubTimestamp":1763454635,"startTime":"0","endTime":"0","summary":"亚盛医药-B北京时间11月18日，跌3.14%，卖空量成交4.53万股，较上一交易日减少56.36%更多个股卖空数据请看下面视窗：卖空数据是观测市场多空博弈的关键指标：短期可反映市场情绪，高卖空比例预示看空预期，但极端值可能触发轧空反弹；长期结合基本面恶化则预警下行风险。需注意其局限性：卖空行为包含对冲需求，未必单纯看空；机构可能通过衍生品做空未体现在数据中，且散户跟风易扭曲信号。股市有风险，请谨慎决策。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251118163613950bc5d1&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251118163613950bc5d1&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["06855","BK1574","BK1161"],"gpt_icon":0},{"id":"2584064224","title":"每日卖空追踪 | 亚盛医药-B 11月17日卖空量成交5.46万股，卖空比例为5.01%","url":"https://stock-news.laohu8.com/highlight/detail?id=2584064224","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2584064224?lang=zh_cn&edition=full","pubTime":"2025-11-17 16:30","pubTimestamp":1763368234,"startTime":"0","endTime":"0","summary":"亚盛医药-B北京时间11月17日，跌3.4%，卖空量成交5.46万股，较上一交易日减少76.33%更多个股卖空数据请看下面视窗：卖空数据是观测市场多空博弈的关键指标：短期可反映市场情绪，高卖空比例预示看空预期，但极端值可能触发轧空反弹；长期结合基本面恶化则预警下行风险。需注意其局限性：卖空行为包含对冲需求，未必单纯看空；机构可能通过衍生品做空未体现在数据中，且散户跟风易扭曲信号。股市有风险，请谨慎决策。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251117163556a4a72ef6&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251117163556a4a72ef6&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["06855","BK1574","BK1161"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.ascentagepharma.com","stockEarnings":[{"period":"1week","weight":-0.0094},{"period":"1month","weight":-0.0305},{"period":"3month","weight":-0.1991},{"period":"6month","weight":0.1471},{"period":"1year","weight":0.5691},{"period":"ytd","weight":0.3982}],"compareEarnings":[{"period":"1week","weight":0.0087},{"period":"1month","weight":0.0058},{"period":"3month","weight":0.0262},{"period":"6month","weight":0.0964},{"period":"1year","weight":0.3336},{"period":"ytd","weight":0.3004}],"compareStock":{"symbol":"HSI","name":"恒生指数"},"description":"亚盛医药集团是一家主要从事血液系统恶性肿瘤治疗药物的发现、研发及商业化的控股公司。该公司主营业务是从事开发及销售针对肿瘤、乙肝及衰老相关的疾病的新型小规模疗法。该公司的主要产品包括Olverembatinib（HQP1351）、Lisaftoclax（APG-2575）、Alrizomadlin（APG-115）、Pelcitoclax（APG-1252）、APG-5918等产品。该公司的产品主要用于治疗主要血液系统恶性肿瘤，包括慢性粒细胞白血病、急性粒细胞白血病、慢性淋巴细胞白血病、急性淋巴细胞白血病、骨髓增生异常综合征及多发性骨髓瘤。该公司主要在国内市场开展业务。","yearOnYearQuotes":[{"month":1,"riseRate":0.333333,"avgChangeRate":-0.093585},{"month":2,"riseRate":0.333333,"avgChangeRate":-0.035469},{"month":3,"riseRate":0.166667,"avgChangeRate":-0.10554},{"month":4,"riseRate":0.833333,"avgChangeRate":0.119495},{"month":5,"riseRate":0.5,"avgChangeRate":0.054537},{"month":6,"riseRate":0.833333,"avgChangeRate":0.306068},{"month":7,"riseRate":0.333333,"avgChangeRate":-0.077026},{"month":8,"riseRate":0.833333,"avgChangeRate":0.051008},{"month":9,"riseRate":0.166667,"avgChangeRate":-0.083178},{"month":10,"riseRate":0.5,"avgChangeRate":0.039816},{"month":11,"riseRate":0.428571,"avgChangeRate":0.061723},{"month":12,"riseRate":0.571429,"avgChangeRate":0.071514}],"exchange":"SEHK","name":"亚盛医药-B","nameEN":"ASCENTAGE-B"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.35.9","shortVersion":"4.35.9","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"亚盛医药-B(06855)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供亚盛医药-B(06855)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"亚盛医药-B,06855,亚盛医药-B股票,亚盛医药-B股票老虎,亚盛医药-B股票老虎国际,亚盛医药-B行情,亚盛医药-B股票行情,亚盛医药-B股价,亚盛医药-B股市,亚盛医药-B股票价格,亚盛医药-B股票交易,亚盛医药-B股票购买,亚盛医药-B股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"亚盛医药-B(06855)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供亚盛医药-B(06855)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}